The estimated Net Worth of Christopher D Alafi is at least 10.4 百万$ dollars as of 27 May 2021. Christopher Alafi owns over 47,325 units of Intra-Cellular Therapies Inc stock worth over 7,098,400$ and over the last 10 years he sold ITCI stock worth over 3,017,186$. In addition, he makes 240,737$ as Independent Director at Intra-Cellular Therapies Inc.
Christopher has made over 21 trades of the Intra-Cellular Therapies Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 47,325 units of ITCI stock worth 1,897,733$ on 27 May 2021.
The largest trade he's ever made was buying 625,000 units of Intra-Cellular Therapies Inc stock on 11 March 2015 worth over 15,000,000$. On average, Christopher trades about 39,170 units every 41 days since 2014. As of 27 May 2021 he still owns at least 95,000 units of Intra-Cellular Therapies Inc stock.
You can see the complete history of Christopher Alafi stock trades at the bottom of the page.
Dr. Christopher D. Alafi Ph.D. is an Independent Director of Intra-Cellular Therapies, Inc. Dr. Alafi became a director of the Company following the Merger that occurred in August 2013 and has served on the board of directors of ITI since January 2013. Dr. Alafi has been a Managing Partner of Alafi Capital Company, LLC, a venture capital firm and a principal stockholder of the Company, since 1995. He was previously a Physiology and Anatomy teacher at Santa Monica College, a visiting scholar in the Department of Chemistry at Stanford University and a researcher at DNAX. Dr. Alafi previously served as a director of ISTO Technologies, Coley Pharmaceutical Group, Inc., CyberGold, Inc. and Stereotaxis, Inc. Dr. Alafi received a B.A. in Biology from Pomona College and a D.Phil. in Biochemistry from the University of Oxford.
As the Independent Director of Intra-Cellular Therapies Inc, the total compensation of Christopher Alafi at Intra-Cellular Therapies Inc is 240,737$. There are 13 executives at Intra-Cellular Therapies Inc getting paid more, with Sharon Mates having the highest compensation of 4,724,560$.
Christopher Alafi is 56, he's been the Independent Director of Intra-Cellular Therapies Inc since 2014. There are 12 older and 4 younger executives at Intra-Cellular Therapies Inc. The oldest executive at Intra-Cellular Therapies Inc is Richard Lerner, 81, who is the Independent Director.
Christopher's mailing address filed with the SEC is 8 Admiral Dr, Emeryville, CA 94608, USA.
Over the last 11 years, insiders at Intra-Cellular Therapies Inc have traded over 77,703,646$ worth of Intra-Cellular Therapies Inc stock and bought 3,068,522 units worth 52,322,638$ . The most active insiders traders include Rory B Riggs、Joel S Marcus、Christopher D Alafi. On average, Intra-Cellular Therapies Inc executives and independent directors trade stock every 17 days with the average trade being worth of 2,787,280$. The most recent stock trade was executed by Sharon Mates on 29 August 2024, trading 70,000 units of ITCI stock currently worth 891,100$.
intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.
Intra-Cellular Therapies Inc executives and other stock owners filed with the SEC include: